CHINA SXT PHARMACEUTICALS IN filings

SEC filings by CHINA SXT PHARMACEUTICALS IN (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-09Forsakringsaktiebolaget Avanza PensionChina SXT Pharmaceuticals, Inc.13,437238.0%EDGAR
SC 13G2024-02-09Forsakringsaktiebolaget Avanza PensionChina SXT Pharmaceuticals, Inc.28,680507.0%EDGAR
SC 13G/A2023-03-29Streeterville Capital LLCChina SXT Pharmaceuticals, Inc.00.0%EDGAR
SC 13G2023-03-29Streeterville Capital LLCChina SXT Pharmaceuticals, Inc.1,043,58010.0%EDGAR
SC 13G/A2023-02-13Lind Global Fund II LPChina SXT Pharmaceuticals, Inc.0-EDGAR
SC 13D/A2023-01-30Zhou Albert FengChina SXT Pharmaceuticals, Inc.1,732,04821.5%EDGAR
SC 13G2022-08-25Streeterville Capital LLCChina SXT Pharmaceuticals, Inc.202,93610.0%EDGAR
SC 13G2022-01-21Lind Global Fund II LPChina SXT Pharmaceuticals, Inc.2,575,000-EDGAR
SC 13G/A2021-02-16Ayrton Capital LLCChina SXT Pharmaceuticals, Inc.298,3300.4%EDGAR
SC 13G/A2021-02-11Hudson Bay Capital Management LPChina SXT Pharmaceuticals, Inc.298,3290.5%EDGAR
SC 13G/A2020-02-14Ayrton Capital LLCChina SXT Pharmaceuticals, Inc.2,667,99910.0%EDGAR
SC 13G2020-02-07Hudson Bay Capital Management LPChina SXT Pharmaceuticals, Inc.2,742,13910.0%EDGAR
SC 13G2019-05-08Ayrton Capital LLCChina SXT Pharmaceuticals, Inc.2,000,0007.5%EDGAR
SC 13D2019-02-15Zhou Albert FengChina SXT Pharmaceuticals, Inc.8,500,00037.7%EDGAR